Background: Laparoscopic surgery has proven to be safe and effective. However, the value of laparoscopic resection for malignancy in terms of cancer outcome can only be assessed by large prospective randomized clinical trials with sufficient follow-up. Methods: COLOR (COlon carcinoma Laparoscopic or Open Resection) is a European multicenter randomized trial which has started in September 1997. In 24 hospitals in Sweden, The Netherlands, Germany, France, Italy and Spain, 1,200 patients will be included. The primary end point of the study is cancer-free survival after 3 years. Results: Within <2 years, more than 540 patients have been randomized for right hemicolectomy (45%), left hemicolectomy (10%) and sigmoidectomy (45%). 33 patients (6%) were excluded after randomization. The accrual rate is approximately 25 patients/month. Current survival rates for the whole study group are: stage I: 95%, stage II: 98%, stage III: 93%, stage IV: 64%. For all patients with stage I disease, the mortality was not cancer related. Conclusions: Although laparoscopic surgery appears of value in colorectal malignancy, results of randomized trials have to be awaited to determine the definitive place of laparoscopy in colorectal cancer. Considering the current accrual rate, the COLOR study will be completed in 2002.

Keywords:
Laparoscopy, Colorectal cancer, Multicenter, Randomized trial
1.
Berends FJ, Kazemier G, Bonjer HJ, Lange JF: Subcutaneous metastases after laparoscopic colectomy. Lancet 1994;344:58.
2.
Vukasin P, Ortega AE, Greene FL, Steele GD, Simons AJ, Anthone GJ, Weston LA, Beart RW Jr: Wound recurrence following laparoscopic colon cancer resection: Results of the American Society of Colon and Rectal Surgeons Laparoscopic Registry. Dis Colon Rectum 1996;39(suppl 10):20–23.
3.
Santoro E, Carlini M, Carboni F, Feroce A: Colorectal carcinoma: Laparoscopic versus traditional open surgery. A clinical trial. Hepatogastroenterology 1999;46:900–904.
4.
Poulin EC, Mamazza J, Schlachta CM, Gregoire R, Roy N: Laparoscopic resection does not adversely affect early survival curves in patients undergoing surgery for colorectal adenocarcinoma. Ann Surg 1999;229:487–492.
5.
Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ: Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg 1996;224:694–701.
6.
Watson DI, Mathew G, Ellis T, Baigrie CF, Rofe AM, Jamieson G: Gasless laparoscopy may reduce the risk of port-site metastases following laparascopic tumor surgery. Arch Surg 1997;132:166–168.
7.
Hewett PJ, Thomas WM, King G, Eaton M: Intraperitoneal cell movement during abdominal carbon dioxide insufflation and laparoscopy: An in vivo model. Dis Colon Rectum 1996;39(suppl 10):62–66.
8.
Tseng LN, Berends FJ, Wittich P, Bouvy ND, Marquet RL, Kazemier G, Bonjer HJ: Port-site metastases: Impact of local tissue trauma and gas leakage. Surg Endosc 1998;12:1377–1380.
9.
Whelan RL, Sellers GJ, Allendorf JD, Laird D, Bessler MD, Nowygrod R, Treat MR: Trocar site recurrence is unlikely to result from aerosolization of tumor cells. Dis Colon Rectum 1996;39(suppl 10):7–13.
10.
Fleshman JW, Nelson H, Peters WR, Kim HC, Larach S, Boorse RR, Ambroze W, Leggett P, Bleday R, Stryker S, Christenson B, Wexner S, Senagore A, Rattner D, Sutton J, Fine AP: Early results of laparoscopic surgery for colorectal cancer: Retrospective analysis of 372 patients treated by Clinical Outcomes of Surgical Therapy (COST) Study Group. Dis Colon Rectum 1996;39(suppl 10):53–58.
11.
Franklin ME Jr, Rosenthal D, Abrego-Medina D, Dorman JP, Glass JL, Norem R, Diaz A: Prospective comparison of open vs. laparoscopic colon surgery for carcinoma: Five-year results. Dis Colon Rectum 1996;39(suppl 10):35–46.
12.
Wexner SD, Cohen SM: Port site metastases after laparoscopic colo-rectal surgery for cure of malignancy. Br J Surg 1995;82:295–298.
© 2000 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.